ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 973,03
-0,43%
Dow Jones
44 303,40
-0,99%
DAX
21 787,00
-0,58%
Brent Oil
74,565
0,00%
Bitcoin
96 279,59
-0,28%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. InNexus Biotechnology Inc (CE) (IXSBF) Cours

InNexus Biotechnology Inc (CE)

InNexus Biotechnology Inc (CE) (IXSBF)

USOTC
0,000001
0,00
(0,00%)
Fermé 08 Février 10:00PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,000001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,000001 Plage de 52 semaines 0,000001
Clôture Veille
0,000001
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

IXSBF Dernières nouvelles

Plus de nouvelles

AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Sa

-- Key Data are New Releases for the Company Building on Milestones with Recent FDA Meetings and Technology Discoveries -- DENVER, April 20 /PRNewswire-FirstCall/ -- DXL625 monoclonal antibodies...

20 Avril 2009
PR Newswire (US)

AACR Data Highlights InNexus Preclinical Antibody Candidate

- Additional Presentations Underscore Potency, Binding Capabilities for Antibody Pipeline And Novel Technologies - SCOTTSDALE, Ariz., April 9 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc...

09 Avril 2009
PR Newswire (US)

InNexus Biotechnology Announces a Loan Facility of up to USD$2.5 Million

BRITISH COLUMBIA, Canada, March 25 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...

25 Mars 2009
PR Newswire (US)

InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies

- Company Receives Allowance of Patent Claims in the U.S. and in India - BRITISH COLUMBIA, Canada, March 6 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX...

06 Mars 2009
PR Newswire (US)

FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product

- Agency Supports Company's Production and Clinical and Preclinical Plans for DXL625 - BRITISH COLUMBIA, Canada March 3 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock...

03 Mars 2009
PR Newswire (US)

InNexus Completes Previously Announced Private Placement

BRITISH COLUMBIA, Canada, Jan. 27 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), announced today that it has...

27 Janvier 2009
PR Newswire (US)

InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedule

BRITISH COLUMBIA, Canada, Jan. 13 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...

13 Janvier 2009
PR Newswire (US)

InNexus Biotechnology CEO Named Business Leader of the Year

BRITISH COLUMBIA, Canada, Nov. 17 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...

17 Novembre 2008
PR Newswire (US)

InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placem

- Innovative Biotech Targets Another Large Well-Known Product and Continues Expansion of Antibody Therapeutics Pipeline - BRITISH COLUMBIA, Canada, Nov. 7 /PRNewswire-FirstCall/ -- InNexus...

07 Novembre 2008
PR Newswire (US)

InNexus Biotechnology Receives Patent Grants in Europe

- CEO Morhet to Discuss Continued Expansion of DXL(TM) Patent Protection at 7th Annual BIO Investor Forum - BRITISH COLUMBIA, Canada, Oct. 30 /PRNewswire-FirstCall/ -- InNexus Biotechnology...

30 Octobre 2008
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
26001.0E-61.0E-61.0E-65001.0E-6CS
52001.0E-61.0E-61.0E-61671.0E-6CS
156-9.9E-5-990.00010.00011.0E-6994999.676E-5CS
260-9.9E-5-990.00010.00021.0E-6537158.15E-5CS

IXSBF - Frequently Asked Questions (FAQ)

What is the current InNexus Biotechnology (CE) share price?
The current share price of InNexus Biotechnology (CE) is US$ 0,000001
What is the 1 year trading range for InNexus Biotechnology (CE) share price?
InNexus Biotechnology (CE) has traded in the range of US$ 0,000001 to US$ 0,000001 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SHWZMedicine Man Technologies Inc (CE)
US$ 0,0011
(109 900,00%)
530
ZHCLFZenith Capital Corporation (CE)
US$ 0,10
(99 900,00%)
6k
GNCAQGenocea Biosciences Inc (CE)
US$ 0,0005
(49 900,00%)
2k
CCTLCoin Citadel (PK)
US$ 0,0002
(19 900,00%)
509,6k
TPTWTPT Global Tech Inc (CE)
US$ 0,0002
(19 900,00%)
25,08M
BRGOBergio International Inc (PK)
US$ 0,000001
(-99,00%)
502k
POLCQPolished Inc (CE)
US$ 0,000001
(-99,00%)
130
PUGEPuget Technologies Inc (CE)
US$ 0,000001
(-99,00%)
169k
COSGCosmos Group Holdings Inc (PK)
US$ 0,000001
(-99,00%)
10M
RNWFRenewal Fuels Inc (CE)
US$ 0,000001
(-99,00%)
133
IMTLImage Protect Inc (PK)
US$ 0,0001
(-33,33%)
289,87M
ABQQAB International Group Corporation (PK)
US$ 0,0003
(-25,00%)
286,78M
PDGOParadigm Oil and Gas Inc (PK)
US$ 0,0001
(0,00%)
225,08M
BOMObowmo Inc (PK)
US$ 0,0005
(66,67%)
211,25M
RONNRonn Motor Group Inc (PK)
US$ 0,0003
(0,00%)
187,29M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
IXSBF
InNexus Biotechnology (CE)
TG
E0LD
Enel
BIT
1T
AT&T
LSE
PABS
Lyxor Net Zero
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces